Different methods are available for the treatment of osseous defects. In re
cent years the use of autologous bone was established as the golden standar
d. However, significant disadvantages are limited availability of the bone
graft and its harvest implies additional morbidity for the patient. Alterna
tives to the use of autologous bone, as allogeneic bone from bone banks or
biomaterials like hydroxyapatite are therefore of special interest. However
, the currently available methods have severe disadvantages; allogenic bone
carries a high risk of transmitting infectious diseases, most biomaterials
show an unsatisfying osseous integration as well as prolonged healing with
disability for the patient. Therefore, the aim has to be the development o
f a biomaterial that is as close as possible to human bone. In this in vitr
o study the natural bone mineral Bio-Oss(R)/Orthos(R) was used as a matrix
for human osteoblast like cells isolated from bone marrow of healthy patien
ts. Even after three months the cell showed typical osteblast-like behaviou
r. Histologic evaluation demonstrated the ability of Bio-Oss(R)/Orthos(R) t
o guide cell growth within its matrix structure and therefore mimics in viv
o situation of the healthy bone. The results show that culturing human oste
oblast-like cells under standardised conditions is possible and that the co
mbination of human osteoblast-like cell with an appropriate matrix may have
the potential for a new treatment option of osseous defects.